drugset / Trial / NCT02389218

A Prospective Study of Medical Therapy Against Cryoballoon Ablation in Symptomatic Recent Onset Persistent AF

NCT02389218

Phase 4 Completed 13 enrolled University Hospital, Ghent
RandomizedParallel-groupOpen-labelTreatment

Summary

Prospective trial comparing the efficacy and safety of CryoBalloonAblation (CBA) to standardized medication for treatment of early onset persistent atrial fibrillation (AF) without structural heart disease. The value of CBA in these patients has never been studied; the endpoints for persistent patients are much easier than for paroxysmal patients. Reduction in left atrial (LA) size will be compared versus patients on drug therapy and versus failing patients.

Timeline

Start
2015-03-03
Primary completion
2020-05-14
Completion
2020-05-14

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amiodarone Small molecule
Comparator flecainide Small molecule
Comparator propafenone Unknown
Comparator sotalol Small molecule

Indications